The three major A-share indices fell collectively today. By the close, the Shanghai Stock Exchange Index was down 0.5%, the Shenzhen Securities Index was down 0.87%, the GEM Index was down 0.45%, the Beijing Stock Exchange 50 was down 1.62%, and the Science and Technology Innovation 50 Index was down 1.11%. The total market turnover was 100 million yuan, down from the previous day's volume of 408 billion yuan, and the total market volume was over 4,300 individual stocks. In terms of sector topics, the medical services, CRO concepts, innovative drugs, biological products, and cellular immunotherapy sectors registered the highest gains; the precious metals, education, industrial metals, real estate, and photovoltaic equipment sectors registered the highest declines. On the market, the innovative drug sector surged and declined. Nearly 10 stocks, including Longshen Rongfa, Wanbang Pharmaceutical, Boji Pharmaceutical, and Xinmileage, rose or stopped, while Xinjiangjiang, Shengxiang Biotech, Jinshi Ya Pharmaceutical, and Shu Taishen had the highest gains. Pharmaceutical e-commerce showed active performance. E-Commerce, Magic Pharmaceuticals, and Foci Pharmaceuticals rose and stopped, while Shanghai Kaibao, Biotech Valley, and Liuyao Group followed suit. The precious metals sector continued to decline. Xiaocheng Technology, Zhaojin Gold, and Hunan Baiyin had the highest declines, while Societe Generale Silver Tin, Chifeng Gold, and Shandong Gold followed suit. The decline in the education sector widened at the end of the session, and Intellectual Education hit a standstill. Xueda Education, Onli Education, and Huatu Shanding had the highest declines. Industrial metals also showed weak performance, with Tianshan Aluminum, Zhongfu Industrial, and Hongqiao Holdings leading the decline.

The three major A-share indices fell collectively today. By the close, the Shanghai Stock Exchange Index was down 0.5%, the Shenzhen Securities Index was down 0.87%, the GEM Index was down 0.45%, the Beijing Stock Exchange 50 was down 1.62%, and the Science and Technology Innovation 50 Index was down 1.11%. The total market turnover was 100 million yuan, down from the previous day's volume of 408 billion yuan, and the total market volume was over 4,300 individual stocks. In terms of sector topics, the medical services, CRO concepts, innovative drugs, biological products, and cellular immunotherapy sectors registered the highest gains; the precious metals, education, industrial metals, real estate, and photovoltaic equipment sectors registered the highest declines. On the market, the innovative drug sector surged and declined. Nearly 10 stocks, including Longshen Rongfa, Wanbang Pharmaceutical, Boji Pharmaceutical, and Xinmileage, rose or stopped, while Xinjiangjiang, Shengxiang Biotech, Jinshi Ya Pharmaceutical, and Shu Taishen had the highest gains. Pharmaceutical e-commerce showed active performance. E-Commerce, Magic Pharmaceuticals, and Foci Pharmaceuticals rose and stopped, while Shanghai Kaibao, Biotech Valley, and Liuyao Group followed suit. The precious metals sector continued to decline. Xiaocheng Technology, Zhaojin Gold, and Hunan Baiyin had the highest declines, while Societe Generale Silver Tin, Chifeng Gold, and Shandong Gold followed suit. The decline in the education sector widened at the end of the session, and Intellectual Education hit a standstill. Xueda Education, Onli Education, and Huatu Shanding had the highest declines. Industrial metals also showed weak performance, with Tianshan Aluminum, Zhongfu Industrial, and Hongqiao Holdings leading the decline.